2 completed, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Refractory Anemia With Ring Sideroblasts: new trials by email Literature Review of Refractory Anemia With Ring Sideroblasts trials Research Report on Refractory Anemia With Ring Sideroblasts
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies Fludarabine, Total-Body Irradiation, T Cell-Depleted Donor Lymphocyte Infusion - Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission | Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 35 | 2015-11-13 | 2025-04-24 |
| Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome Allogeneic Bone Marrow Transplantation, Cyclophosphamide, Fludarabine Phosphate - Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission | Phase 1 | Terminated | Fred Hutchinson Cancer Center | 26 | 2007-10-05 | 2023-02-09 |
| Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders Cyclosporine, Fludarabine Phosphate, Laboratory Biomarker Analysis - Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia | Phase 2 | Completed | Fred Hutchinson Cancer Center | 77 | 2006-01-01 | 2020-01-31 |
Anemia, Refractory, with Excess of Blasts (3) · Leukemia, Myelomonocytic, Chronic (3) · Anemia, Refractory (2) · Myeloproliferative Disorders (2) · Anemia, Aplastic (1) · Hemoglobinuria, Paroxysmal (1) · Hodgkin Disease (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1) · Neoplasms (1) · Polycythemia Vera (1) · Primary Myelofibrosis (1) · Thrombocythemia, Essential (1)
Anemia (3) · Bone Marrow Diseases (3) · Chronic Disease (3) · Disease Attributes (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Leukemia (3) · Leukemia, Myeloid (3) · Myelodysplastic-Myeloproliferative Diseases (3) · Neoplasms by Histologic Type (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Hemorrhagic Disorders (2) · Myelodysplastic Syndromes (2) · Neoplasms (2)
Mycophenolic Acid (3) · Whole-Body Irradiation (3) · fludarabine phosphate (3) · Cyclophosphamide (2) · Peripheral Blood Stem Cell Transplantation (2) · Tacrolimus (2) · Cyclosporine (1) · Cyclosporins (1) · Iodine-131 (1) · fludarabine (1)
Fred Hutchinson Cancer Center (2) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)
United States (3)
Brenda Sandmaier (1) · Johnnie Orozco (1) · Usama Gergis, MD (1)
PMID 30630975, PMID 32499241, PMID 37939122
P01CA018029 (1), P01CA044991 (1), P30CA015704 (1)